For five years, John Eldridge and his team at Profectus Bioscience have developed and tested their Ebola vaccine. First it was on guinea pigs, then monkeys.
At that point, Eldridge realized monkeys weren’t getting sick.
{iframe}http://www.marketplace.org/topics/health-care/barda-venture-capital-firm-buried-us-government{/iframe}